Manipur Conflict: A Critical Analysis of the Impact on Kuki Community
Academia Lasalliana Journal of Education and Humanities · 2025
DOI: 10.55902/dwwf8843 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academia Lasalliana Journal of Education and Humanities, 2025. Verfasst von Sonkhothang Haokip.
Abstract (Originalsprache)
This paper examines the Kuki-Meitei conflict in Manipur, which has inflicted heavy losses on the Kuki population. More than 224 Kukis were killed during the conflict, which extended from May 3, 2023 until November 2024. As many as 196 Kuki villages were torched in various locations owing to the long-standing ethnic conflict, and 95 Kuki churches were unfortunately brought to ashes. The conflict has also resulted in grievous injuries, with 90 Kuki village volunteers and civilians injured between May 3, 2023, and November 2024. This article also investigates the causes of Kuki casualties and causes of injury in the conflict. It also identifies the names of the dead, villages or places of residence, districts, and dates of death; the names of churches that were set on fire; and victim villages and districts. It highlights the villages that were destroyed, the dates of incidents in different districts, and the names of village chiefs. The findings, therefore, indicate that there must be humanitarian assistance, negotiation, and reconciliation to minimize the destructive impact of the conflict.
Zitieren
APA
Haokip, S. (2025). Manipur Conflict: A Critical Analysis of the Impact on Kuki Community. Academia Lasalliana Journal of Education and Humanities. https://doi.org/10.55902/dwwf8843
Vancouver
Haokip S. Manipur Conflict: A Critical Analysis of the Impact on Kuki Community. Academia Lasalliana Journal of Education and Humanities. 2025. doi:10.55902/dwwf8843
BibTeX
@article{Haokip2025,
author = {Haokip, Sonkhothang},
title = {Manipur Conflict: A Critical Analysis of the Impact on Kuki Community},
journal = {Academia Lasalliana Journal of Education and Humanities},
year = {2025},
doi = {10.55902/dwwf8843}
}
EUVIMED